S1P3 receptor inhibitors for treating inflammation

Details for Australian Patent Application No. 2009225747 (hide)

Owner Allergan, Inc.

Inventors Dibas, Mohammed I.; Donello, John E.

Agent Davies Collison Cave

Pub. Number AU-A-2009225747

PCT Pub. Number WO2009/117335

Priority 61/037,250 17.03.08 US

Filing date 16 March 2009

Wipo publication date 24 September 2009

International Classifications

A61K 31/404 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/663 (2006.01)

Event Publications

14 October 2010 PCT application entered the National Phase

  PCT publication WO2009/117335 Priority application(s): WO2009/117335

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009225748-Method for imaging the Earth's subsurface using passive seismic sensing

2009225744-Kerosene base fuel